ストックスクリーナーアプリを入手
1.675
10.19%
-0.19
プレマーケット:
1.68
0.005
+0.30%
前日終値:
$1.865
開ける：
$1.86
24時間の取引高:
576.52K
Relative Volume:
1.40
時価総額：
$39.55M
収益：
$160.43M
当期純損益:
$-227.64M
株価収益率:
-0.0244
EPS:
-68.77
ネットキャッシュフロー:
$-170.79M
1週間 パフォーマンス:
-28.72%
1か月 パフォーマンス:
-52.14%
6か月 パフォーマンス:
-73.24%
1年 パフォーマンス:
-87.28%
1日の値動き範囲:
$1.67
$1.94
1週間の範囲:
$1.67
$2.42
52週間の値動き範囲:
$1.67
$19.69
Agenus Inc Stock (AGEN) Company Profile
AGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
1.675 | 39.55M | 160.43M | -227.64M | -170.79M | -68.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-07-18 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-07-18 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-06-06 | 開始されました | Robert W. Baird | Outperform |
| 2023-02-28 | 再開されました | H.C. Wainwright | Buy |
| 2022-09-28 | 開始されました | SMBC Nikko | Outperform |
| 2021-12-16 | 開始されました | H.C. Wainwright | Buy |
| 2019-11-19 | 再開されました | B. Riley FBR | Buy |
| 2019-04-22 | 開始されました | B. Riley FBR | Buy |
| 2016-10-28 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | 繰り返されました | Maxim Group | Buy |
| 2016-03-11 | アップグレード | Maxim Group | Hold → Buy |
| 2015-12-16 | 開始されました | Jefferies | Buy |
| 2015-10-27 | ダウングレード | Maxim Group | Buy → Hold |
| 2015-07-27 | 繰り返されました | MLV & Co | Buy |
| 2015-06-11 | 開始されました | Oppenheimer | Outperform |
| 2015-01-12 | 繰り返されました | Maxim Group | Buy |
| 2015-01-09 | 繰り返されました | MLV & Co | Buy |
| 2015-01-09 | 繰り返されました | Maxim Group | Buy |
| 2014-12-19 | 繰り返されました | Maxim Group | Buy |
| 2014-05-08 | 繰り返されました | Maxim Group | Buy |
| 2014-03-14 | 繰り返されました | MLV & Co | Buy |
| 2013-10-08 | 繰り返されました | Maxim Group | Buy |
| 2012-01-05 | 開始されました | William Blair | Outperform |
| 2011-12-01 | 開始されました | Global Hunter Securities | Buy |
すべてを表示
Agenus Inc (AGEN) 最新ニュース
Equities Analysts Offer Predictions for Agenus Q1 Earnings - Defense World
HC Wainwright Reaffirms Neutral Rating for Agenus (NASDAQ:AGEN) - Defense World
Agenus stock falls after revenue miss - MSN
Agenus (AGEN) Q4 2024 Earnings Call Transcript - AOL
Agenus stock hits 52-week low at $1.91 amid market challenges - Investing.com Australia
Agenus Inc. Earnings Call: Mixed Sentiments and Strategic Focus - TipRanks
Agenus stock hits 52-week low at $1.91 amid market challenges By Investing.com - Investing.com South Africa
Agenus Inc. (NASDAQ:AGEN) Q4 2024 Earnings Call Transcript - MSN
Agenus’ Strategic Cost Reductions and CRC Focus Lead to Hold Rating - TipRanks
Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Moves Amid Financial Challenges - Yahoo Finance
Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Mo - GuruFocus.com
Agenus Inc. Reports Strategic Cost Reductions and BOT/BAL Progress - TipRanks
Agenus: Q4 Earnings Snapshot - mySA
Agenus stock falls as Q4 revenue drops sharply By Investing.com - Investing.com South Africa
Earnings call transcript: Agenus sees stock jump in Q4 2024 - Investing.com India
Earnings call transcript: Agenus sees stock jump in Q4 2024 By Investing.com - Investing.com UK
Agenus Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Agenus: Q4 Earnings Snapshot -March 11, 2025 at 07:44 am EDT - Marketscreener.com
Agenus to lower annual burn to about $50 mln by mid-2025 -March 11, 2025 at 07:40 am EDT - Marketscreener.com
Agenus Slashes Cash Burn by 50% While Advancing Promising Cancer Drug Program - StockTitan
Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program - Bluefield Daily Telegraph
Earnings Scheduled For March 11, 2025 - Benzinga
Class Action Filed Against Agenus Inc. (AGEN) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Contrasting Agenus (NASDAQ:AGEN) and Cortexyme (NASDAQ:CRTX) - Defense World
Agenus (AGEN) Projected to Post Earnings on Tuesday - Defense World
Agenus Inc. to Host Earnings Call - ACCESS Newswire
Agenus stock touches 52-week low at $2.48 amid market challenges - Investing.com Australia
Agenus stock touches 52-week low at $2.48 amid market challenges By Investing.com - Investing.com South Africa
Agenus reports promising sarcoma study results - MSN
AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Shareholders that lost money on Agenus Inc.(AGEN) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Levi & Korsinsky Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineAGEN - ACCESS Newswire
AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AGEN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Shareholders That Lost Money on Agenus Inc. (AGEN) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Investors who lost money on Agenus Inc.(AGEN) should contact Levi & Korsinsky about pending Class ActionAGEN - ACCESS Newswire
Agenus, Inc. to Host Earnings Call - ACCESS Newswire
Agenus Inc. revises financial agreements, extends warrant terms - Investing.com India
Agenus Inc. revises financial agreements, extends warrant terms By Investing.com - Investing.com South Africa
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - ACCESS Newswire
Levi & Korsinsky Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024AGEN - ACCESS Newswire
Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications - Business Wire
Can Agenus Breakthrough in Colorectal Cancer? CCO to Reveal Strategy at Major Oncology Conference - StockTitan
When Will Agenus Reveal Its 2024 Performance? Key Date for Biotech Investors - StockTitan
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report - Business Wire
Agenus Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - ACCESS Newswire
Can This Novel Triple Immunotherapy Crack the Code for Treatment-Resistant Gastric Cancer? - StockTitan
Agenus Inc (AGEN) 財務データ
収益
当期純利益
現金流量
EPS
1.39%
0.55%
大文字化:
|
ボリューム (24 時間):